We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$17.3B
AUM Growth
+$91.5M
Cap. Flow
+$336M
Cap. Flow %
1.94%
Top 10 Hldgs %
59.81%
Holding
1,066
New
76
Increased
460
Reduced
487
Closed
41

Sector Composition

Rank Sector Weight
1 Energy 68.28%
2 Technology 4.29%
3 Financials 3.4%
4 Consumer Discretionary 2.95%
5 Materials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
926
HCA Healthcare
HCA
$84.8B
$312K ﹤0.01%
815
-517
-39% -$186K
BVN icon
927
Compañía de Minas Buenaventura
BVN
$7.85B
$310K ﹤0.01%
18,890
+2,021
+12% +$30.7K
AA icon
928
Alcoa
AA
$11.7B
$309K ﹤0.01%
10,456
+126
+1% +$3.4K
AXTA icon
929
Axalta
AXTA
$7.01B
$308K ﹤0.01%
10,376
+126
+1% +$3.92K
STWD icon
930
Starwood Property Trust
STWD
$6.12B
$308K ﹤0.01%
15,344
-578
-4% -$11.2K
MAR icon
931
Marriott International
MAR
$98.7B
$304K ﹤0.01%
1,114
-627
-36% -$157K
COKE icon
932
Coca-Cola Consolidated
COKE
$12.3B
$304K ﹤0.01%
2,720
+30
+1% +$3.62K
XNCR icon
933
Xencor
XNCR
$1.44B
$302K ﹤0.01%
38,399
-13,060
-25% -$117K
GBX icon
934
The Greenbrier Companies
GBX
$1.61B
$302K ﹤0.01%
6,549
+79
+1% +$3.54K
HALO icon
935
Halozyme
HALO
$9.72B
$299K ﹤0.01%
5,756
+70
+1% +$3.98K
TBPH icon
936
Theravance Biopharma
TBPH
$874M
$298K ﹤0.01%
27,007
-9,072
-25% -$88.2K
EMN icon
937
Eastman Chemical
EMN
$7.8B
$298K ﹤0.01%
3,988
+48
+1% +$3.77K
SLB icon
938
SLB Ltd
SLB
$77.8B
$297K ﹤0.01%
8,776
+106
+1% +$3.68K
TAP icon
939
Molson Coors Class B
TAP
$7.68B
$295K ﹤0.01%
6,124
+74
+1% +$4.08K
KROS icon
940
Keros Therapeutics
KROS
$199M
$293K ﹤0.01%
21,949
-7,787
-26% -$105K
WLFC icon
941
Willis Lease Finance
WLFC
$1.65B
$292K ﹤0.01%
6,132
+222
+4% +$10.5K
INDA icon
942
iShares MSCI India ETF
INDA
$6.71B
$292K ﹤0.01%
5,239
-625
-11% -$33.4K
LNTH icon
943
Lantheus
LNTH
$6.82B
$290K ﹤0.01%
3,544
+43
+1% +$3.78K
TPL icon
944
Texas Pacific Land
TPL
$28.9B
$289K ﹤0.01%
822
+9
+1% +$3.68K
MAZE
945
Maze Therapeutics
MAZE
$1.53B
$289K ﹤0.01%
+23,577
New +$245K
LQDT icon
946
Liquidity Services
LQDT
$1.17B
$287K ﹤0.01%
12,157
+147
+1% +$3.96K
ONL
947
Orion Office REIT
ONL
$148M
$285K ﹤0.01%
133,625
+21,510
+19% +$41K
BF.A icon
948
Brown-Forman Class A
BF.A
$12.3B
$284K ﹤0.01%
10,325
+125
+1% +$4.01K
MDXG icon
949
MiMedx Group
MDXG
$626M
$283K ﹤0.01%
46,237
+1,547
+3% +$10.3K
REGN icon
950
Regeneron Pharmaceuticals
REGN
$68.8B
$281K ﹤0.01%
536
+6
+1% +$3.35K

Similar funds

ALPS Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, ALPS Advisors held 1,066 positions worth $17.3B, up 0.53% from $17.2B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

ALPS Advisors's Q2 2025 filing shows 76 new, 460 increased, 487 reduced and 41 closed positions. Its largest new stake was ALPS Dynamic US Dividend Advantage ETF: 231,612 shares worth $13.4M. The largest sale was Schwab Fundamental US Large Company Index ETF, an estimated $32.7M.

By sector, the portfolio is most concentrated in Energy at 68% of assets, down from 70% a quarter earlier, followed by Technology and Financials.

  • ALPS Advisors's largest Q2 2025 buy was ALPS Dynamic US Dividend Advantage ETF: 231,612 shares worth $13.4M.
  • ALPS Advisors added most to Hess Midstream in Q2 2025, an estimated $99M increase.
  • ALPS Advisors's biggest Q2 2025 reduction was Energy Transfer Partners, cutting an estimated $18.7M.
  • ALPS Advisors fully exited Schwab Fundamental US Large Company Index ETF in Q2 2025, selling an estimated $32.7M.
  • ALPS Advisors's ten largest holdings make up 60% of its $17.3B portfolio in Q2 2025.
  • ALPS Advisors opened 76 new positions and closed 41 in Q2 2025.
  • ALPS Advisors's portfolio value rose 0.53% quarter-over-quarter to $17.3B.

Based on ALPS Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.